FDA PMA FDA Class 3 Approved 🇺🇸 United States

Stent, Coronary

PMA: P110004 · Supplement: S024 · Decision Mar 7, 2018
Classifications
1
FEI Numbers
28
Registration Numbers
28

Basic Information

Device Name
Stent, Coronary
Trade Name
NIRxcell CoCr Coronary Stent on RX System
PMA Number
P110004
Supplement Number
S024
Device Class
FDA Class 3
Product Code
MAF
Generic Name
STENT, CORONARY
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 7, 2018
Date Received
July 17, 2017
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Approval for a manufacturing site located at Creganna Medical, 8 Admiralty Street, #07-10 Admirax Building, Singapore, for the manufacturing of D-Catheter delivery system.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MAF Stent, Coronary